62 b. Comme marqueur d'une atteinte vasculaire, p.63 ,
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, vol.51, issue.6, pp.1017-1043, 2012. ,
DOI : 10.1093/rheumatology/ker269
Increased pigmentation in scleroderma, J Rheumatol, vol.23, pp.1912-1918, 1996. ,
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.62, issue.(Suppl), pp.2737-2784, 2013. ,
DOI : 10.1002/art.27580
Immunoreactive beta-melanocyte-stimulating hormone and melanin pigmentation in systemic sclerosis., BMJ, vol.2, issue.6038, pp.733-737, 1976. ,
DOI : 10.1136/bmj.2.6038.733-a
URL : http://static.www.bmj.com/content/bmj/2/6038/733.2.full.pdf
Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation, British Journal of Dermatology, vol.33, issue.1, pp.199-200, 2001. ,
DOI : 10.1016/0190-9622(95)91274-6
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?, J Rheumatol, vol.21, pp.1838-1882, 1994. ,
Significance of plasma endothelin-1 levels in patients with systemic sclerosis, J Rheumatol, vol.19, pp.1566-71, 1992. ,
Elevated plasma endothelin levels in systemic sclerosis, Archives of Dermatological Research, vol.39, issue.5, pp.439-481, 1995. ,
DOI : 10.1007/BF00373425
Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis, International Journal of Dermatology, vol.3, issue.12, pp.899-902, 2000. ,
DOI : 10.1136/bmj.2.6038.733-a
Overview of pathogenesis of systemic sclerosis, Rheumatology, vol.48, issue.suppl_3, pp.3-7, 2009. ,
DOI : 10.1093/rheumatology/ken481
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database, Annals of the Rheumatic Diseases, vol.66, issue.6, pp.754-63, 2007. ,
DOI : 10.1136/ard.2006.062901
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database, Annals of the Rheumatic Diseases, vol.66, issue.6 ,
DOI : 10.1136/ard.2006.062901
Incidence of scleroderma spectrum disorders in Slovenia, Clin. Exp. Rheumatol, vol.31, pp.8-11, 2013. ,
Systemic Sclerosis in Northwestern Spain, Medicine, vol.87, issue.5, pp.272-280, 2008. ,
DOI : 10.1097/MD.0b013e318189372f
Prevalence of systemic sclerosis in a French multi-ethnic county, Rheumatology, vol.43, issue.9, pp.1129-1137, 2004. ,
DOI : 10.1093/rheumatology/keh253
Nouvelles donn??es sur la pr??valence de la scl??rodermie syst??mique en France, La Revue de M??decine Interne, vol.30, p.74, 2009. ,
DOI : 10.1016/j.revmed.2009.03.128
Racial differences in scleroderma among women in Michigan, Arthritis & Rheumatism, vol.110, issue.4, pp.734-742, 1997. ,
DOI : 10.1161/01.CIR.21.6.1088
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.1780400421/pdf
Race and Association With Disease Manifestations and Mortality in Scleroderma, Medicine, vol.92, issue.4, pp.191-205, 2013. ,
DOI : 10.1097/MD.0b013e31829be125
URL : http://pdfs.journals.lww.com/md-journal/2013/07000/Race_and_Association_With_Disease_Manifestations.1.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1504238919418;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzddFRrD2hcIwdDP9eSnSkfs2/GTuiz1vf54CNU1ZiHpkg=;hash|HzIOlSMX9WvyhEhftRQw/g==
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis, Arthritis & Rheumatism, vol.13, issue.Suppl, pp.2986-2994, 2012. ,
DOI : 10.1097/RHU.0b013e318124a89e
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts, Arthritis & Rheumatism, vol.38, issue.6, pp.1359-1362, 2001. ,
DOI : 10.1002/art.1780381219
URL : http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S/pdf
Physiopathologie de la sclérodermie systémique. médecine/sciences 32, pp.183-191, 2016. ,
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J. Rheumatol, vol.15, pp.202-205, 1988. ,
Criteria for the classification of early systemic sclerosis, J. Rheumatol, vol.28, pp.1573-1576, 2001. ,
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.62, issue.(Suppl), pp.2737-2747, 2013. ,
DOI : 10.1002/art.27580
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, vol.51, issue.6, pp.1017-1026, 2012. ,
DOI : 10.1093/rheumatology/ker269
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Annals of the Rheumatic Diseases, vol.69, issue.10, pp.1809-1815, 2010. ,
DOI : 10.1136/ard.2009.114264
Systemic Sclerosis, Medicine, vol.81, issue.2, pp.139-153, 2002. ,
DOI : 10.1097/00005792-200203000-00004
Predicting Mortality in Systemic Sclerosis, Medicine, vol.81, issue.2, pp.154-167, 2002. ,
DOI : 10.1097/00005792-200203000-00005
Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients, The Journal of Rheumatology, vol.39, issue.10, pp.1971-1978, 2012. ,
DOI : 10.3899/jrheum.111582
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.476-481, 2011. ,
DOI : 10.1136/ard.2010.136929
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J. Rheumatol, vol.27, pp.155-160, 2000. ,
Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database, Microvascular Research, vol.89, pp.122-128, 2013. ,
DOI : 10.1016/j.mvr.2013.06.003
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial, Arthritis & Rheumatism, vol.78, issue.11, pp.2445-2454, 2000. ,
DOI : 10.1093/biomet/78.3.691
Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China, Clin. Exp. Rheumatol, vol.33, pp.106-110, 2015. ,
Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease, Arthritis Care & Research, vol.33, issue.Suppl 91, pp.1021-1027, 2016. ,
DOI : 10.1002/art.24394
Digital ulcers: overt vascular disease in systemic sclerosis, Rheumatology, vol.48, issue.suppl_3, pp.19-24, 2009. ,
DOI : 10.1093/rheumatology/kep105
URL : https://academic.oup.com/rheumatology/article-pdf/48/suppl_3/iii19/18096586/kep105.pdf
Natural history of ischemic digital ulcers in systemic sclerosis: singlecenter retrospective longitudinal study, J. Rheumatol, vol.34, pp.2423-2430, 2007. ,
Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist, Arthritis & Rheumatism, vol.132, issue.12, pp.3985-3993, 2004. ,
DOI : 10.7326/0003-4819-132-6-200003210-00002
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind ,
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis, Rheumatology, vol.54, issue.1, pp.72-76, 2015. ,
DOI : 10.1093/rheumatology/keu296
Digital ulcers predict a worse disease course in patients with systemic sclerosis, Annals of the Rheumatic Diseases, vol.70, issue.(Suppl 2), pp.681-686, 2016. ,
DOI : 10.1136/ard.2010.132431
Intrarenal Hemodynamic Parameters Correlate with Glomerular Filtration Rate and Digital Microvascular Damage in Patients with Systemic Sclerosis, Seminars in Arthritis and Rheumatism, vol.41, issue.6, pp.815-821, 2012. ,
DOI : 10.1016/j.semarthrit.2011.11.005
Increased Intrarenal Arterial Stiffness May Predict the Occurrence of New Digital Ulcers in Systemic Sclerosis, Arthritis Care & Research, vol.39, issue.Suppl 7, pp.1380-1385, 2014. ,
DOI : 10.1002/art.1780390622
Calcinosis in systemic sclerosis: subsets, distribution and complications, Rheumatology, vol.55, issue.9, pp.1610-1614, 2016. ,
DOI : 10.1093/rheumatology/kew193
Guidelines for the diagnosis and treatment of pulmonary hypertension, ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), pp.2493-2537, 2009. ,
DOI : 10.1016/j.repce.2011.10.006
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies, The Journal of Rheumatology, vol.37, issue.11, pp.2290-2298, 2010. ,
DOI : 10.3899/jrheum.100245
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial, The Lancet, vol.371, issue.9630, pp.2093-2100, 2008. ,
DOI : 10.1016/S0140-6736(08)60919-8
Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Arthritis & Rheumatism, vol.64, issue.12, pp.3194-3201, 2013. ,
DOI : 10.1002/acr.21641
Kidney involvement in systemic sclerosis Presse Medicale Paris Fr, pp.305-314, 1983. ,
DOI : 10.1016/j.lpm.2014.02.031
Gastrointestinal motility disorder assessment in systemic sclerosis, Rheumatology, vol.52, issue.6, pp.1095-1100, 2013. ,
DOI : 10.1093/rheumatology/kes429
URL : https://academic.oup.com/rheumatology/article-pdf/52/6/1095/5201236/kes429.pdf
Heart involvement in systemic sclerosis]. Presse Medicale Paris Fr, pp.1938-1942, 1983. ,
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis, Annals of the Rheumatic Diseases, vol.69, issue.01, pp.218-221, 2010. ,
DOI : 10.1136/ard.2008.103382
Assessment of heart involvement, Clin. Exp. Rheumatol, vol.21, pp.24-28, 2003. ,
Musculoskeletal Manifestations of Systemic Sclerosis, Rheumatic Disease Clinics of North America, vol.41, issue.3, pp.507-518, 2015. ,
DOI : 10.1016/j.rdc.2015.04.011
Articular involvement in systemic sclerosis, Rheumatology, vol.51, issue.8, pp.1347-1356, 2012. ,
DOI : 10.1093/rheumatology/kes041
URL : https://academic.oup.com/rheumatology/article-pdf/51/8/1347/5212440/kes041.pdf
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database, Annals of the Rheumatic Diseases, vol.71, issue.8, pp.1355-1360, 2012. ,
DOI : 10.1136/annrheumdis-2011-200742
Myopathy in scleroderma and in other connective tissue diseases, Current Opinion in Rheumatology, vol.28, issue.6, pp.631-635, 2016. ,
DOI : 10.1097/BOR.0000000000000336
Systemic Scleroderma, Archives of Dermatology, vol.84, issue.3, pp.359-371, 1961. ,
DOI : 10.1001/archderm.1961.01580150005001
Profile of systemic sclerosis in a tertiary care center in North India, Indian Journal of Dermatology, Venereology and Leprology, vol.72, issue.6, pp.416-420, 2006. ,
DOI : 10.4103/0378-6323.29336
Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants, Seminars in Arthritis and Rheumatism, vol.30, issue.5, pp.332-346, 2001. ,
DOI : 10.1053/sarh.2001.20268
On diffuse scleroderma: with special reference to diagnosis, and to the use of the thyroid-gland extract, J Cutan Dis, vol.16, p.49, 1898. ,
Vitiligolike Macules in Systemic Scleroderma, Archives of Dermatology, vol.119, issue.2, pp.129-133, 1983. ,
DOI : 10.1001/archderm.1983.01650260037013
Scleroderma (systemic sclerosis) among Nigerians, Clinical Rheumatology, vol.22, issue.4, pp.1121-1125, 2009. ,
DOI : 10.1016/S0025-6196(12)60294-8
Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis, International Journal of Rheumatic Diseases, vol.71, issue.11, pp.767-773, 2017. ,
DOI : 10.1136/annrheumdis-2011-200742
Vitiligo-like depigmentation with perifollicular pigment retention in systemic sclerosis treated successfully with suplatast tosilate, Eur. J. Dermatol. EJD, vol.26, pp.110-112, 2016. ,
Immunoreactive beta-melanocyte-stimulating hormone and melanin pigmentation in systemic sclerosis., BMJ, vol.2, issue.6038, pp.733-734, 1976. ,
DOI : 10.1136/bmj.2.6038.733-a
URL : http://static.www.bmj.com/content/bmj/2/6038/733.2.full.pdf
Increased pigmentation in scleroderma, J. Rheumatol, vol.23, pp.1912-1916, 1996. ,
A new skin manifestation of progressive systemic sclerosis, Journal of the American Academy of Dermatology, vol.11, issue.2, pp.265-268, 1984. ,
DOI : 10.1016/S0190-9622(84)70163-0
Hyperpigmentation along tendons in progressive systemic sclerosis, J. Rheumatol, vol.13, pp.474-475, 1986. ,
Hyperpigmentation of the skin along the thoracic and lumbar spine in progressive systemic sclerosis, J. Rheumatol, vol.18, pp.1946-1947, 1991. ,
The belt sign in scleroderma, J. Rheumatol, vol.17, pp.725-726, 1990. ,
Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosis, Clinical and Experimental Dermatology, vol.76, issue.4, pp.379-382, 2016. ,
DOI : 10.1111/j.1365-3083.2012.02757.x
Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature, Journal of Medical Case Reports, vol.23, issue.1, p.219, 2015. ,
DOI : 10.1046/j.1365-2133.2001.03983.x
Reticulate hyperpigmented scleroderma: a new pigmentary manifestation, Clinical and Experimental Dermatology, vol.39, issue.2, pp.131-133, 2005. ,
DOI : 10.1001/archderm.119.2.129
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?, J. Rheumatol, vol.21, pp.1838-1844, 1994. ,
Significance of plasma endothelin-1 levels in patients with systemic sclerosis, J. Rheumatol, vol.19, pp.1566-1571, 1992. ,
Elevated plasma endothelin levels in systemic sclerosis, Archives of Dermatological Research, vol.39, issue.5, pp.439-442, 1995. ,
DOI : 10.1007/BF00373425
Overview of pathogenesis of systemic sclerosis, Rheumatology, vol.48, issue.suppl_3, pp.3-7, 2009. ,
DOI : 10.1093/rheumatology/ken481
The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review, Autoimmunity Reviews, vol.16, issue.8, 2017. ,
DOI : 10.1016/j.autrev.2017.05.024
Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis, International Journal of Dermatology, vol.3, issue.12, pp.899-902, 2000. ,
DOI : 10.1136/bmj.2.6038.733-a
Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation, British Journal of Dermatology, vol.33, issue.1, pp.199-200, 2001. ,
DOI : 10.1016/0190-9622(95)91274-6